Cardiovascular Admissions and Mortality in an Inception Cohort of Patients with Rheumatoid Arthritis with Onset in the 1980s and 1990s

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 2005 Apr 22

PMID 15843450

Citations 79

Authors

N Goodson

J Marks

M Lunt

D Symmons

Affiliations

Soon will be listed here.

Abstract

Background: There is increased cardiovascular disease mortality in rheumatoid arthritis. This may reflect an increased prevalence of cardiovascular disease or an increased case fatality in patients with rheumatoid arthritis.

Objectives: To examine whether rheumatoid patients with disease onset in the 1980s-1990s have increased mortality, and to compare cardiovascular admission rates in rheumatoid patients with those of the general population.

Methods: An inception cohort of 1010 rheumatoid patients attending Stockport rheumatology clinics between 1981 and 1996 was followed up to December 2002 through the Office for National Statistics. Standardised mortality ratios (SMR) were calculated for all-cause and cause specific mortality, using the population of Stockport as reference. Cardiovascular disease admission rates were ascertained for a subgroup of patients using national hospital episode statistics; standardised cardiovascular disease admission rates (SAR) and SMRs were calculated for this subgroup.

Results: 470 patients (48%) died during a median follow up of 11.4 years. All-cause mortality was increased in men (SMR = 1.45 (95% confidence interval, 1.22 to 1.71)) and women (SMR = 1.84 (1.64 to 2.05)), as was cardiovascular disease mortality in men (SMR = 1.36 (1.04 to 1.75) and women (SMR = 1.93 (1.65 to 2.26)). No difference in cardiovascular disease admission rates was observed in men (SAR 1.20 (0.89 to 1.58) or women (SAR = 1.10 (0.88 to 1.36)), despite excess cardiovascular disease mortality in this subgroup.

Conclusions: Patients with rheumatoid arthritis have reduced life expectancy and excess cardiovascular disease mortality. Nevertheless, standardised admission rates for cardiovascular disease were not raised. This suggests either that cardiovascular disease in rheumatoid arthritis has a higher case fatality than in the general population or that it often goes unrecognised before the fatal event.

Citing Articles

[Energy metabolism of the immune system : Consequences in chronic inflammation].

Straub R, Pongratz G, Buttgereit F, Gaber T Z Rheumatol. 2023; 82(6):479-490.

PMID: 37488246 DOI: 10.1007/s00393-023-01389-4.

Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents.

Infante M, Padilla N, Alejandro R, Caprio M, Della-Morte D, Fabbri A Medicina (Kaunas). 2022; 58(5).

PMID: 35629988 PMC: 9143119. DOI: 10.3390/medicina58050571.

Systemic Adverse Effects Induced by the BNT162b2 Vaccine Are Associated with Higher Antibody Titers from 3 to 6 Months after Vaccination.

Koike R, Sawahata M, Nakamura Y, Nomura Y, Katsube O, Hagiwara K Vaccines (Basel). 2022; 10(3).

PMID: 35335084 PMC: 8950942. DOI: 10.3390/vaccines10030451.

Association between Carotid Intima-Media Thickness and the Use of Biological or Small Molecule Therapies in Patients with Rheumatoid Arthritis.

Rojas-Gimenez M, Lopez-Medina C, Calvo-Gutierrez J, Puche-Larrubia M, Gomez-Garcia I, Segui-Azpilcueta P Diagnostics (Basel). 2022; 12(1).

PMID: 35054229 PMC: 8775122. DOI: 10.3390/diagnostics12010064.

Postprandial Hyperlipidemia: Association with Inflammation and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis.

Mena-Vazquez N, Redondo-Rodriguez R, Rioja J, Jimenez-Nunez F, Manrique-Arija S, Lisbona-Montanez J Biomedicines. 2022; 10(1).

PMID: 35052812 PMC: 8773280. DOI: 10.3390/biomedicines10010133.

References

Sokka T, Mottonen T, Hannonen P . Mortality in early "sawtooth" treated rheumatoid arthritis patients during the first 8-14 years. Scand J Rheumatol. 1999; 28(5):282-7. DOI: 10.1080/03009749950155463. View

Gabriel S, Crowson C, OFallon W . Mortality in rheumatoid arthritis: have we made an impact in 4 decades?. J Rheumatol. 1999; 26(12):2529-33. View

Kvalvik A, Jones M, Symmons D . Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992. Scand J Rheumatol. 2000; 29(1):29-37. DOI: 10.1080/030097400750001770. View

Kroot E, van Leeuwen M, van Rijswijk M, Prevoo M, van t Hof M, van de Putte L . No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset. Ann Rheum Dis. 2000; 59(12):954-8. PMC: 1753055. DOI: 10.1136/ard.59.12.954. View

Chehata J, Hassell A, Clarke S, Mattey D, Jones M, Jones P . Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activity. Rheumatology (Oxford). 2001; 40(4):447-52. DOI: 10.1093/rheumatology/40.4.447. View

Riise T, Jacobsen B, Gran J, Haga H, Arnesen E . Total mortality is increased in rheumatoid arthritis. A 17-year prospective study. Clin Rheumatol. 2001; 20(2):123-7. DOI: 10.1007/pl00011191. View

Ward M . Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs?. Arthritis Rheum. 2001; 44(6):1467-9. DOI: 10.1002/1529-0131(200106)44:6<1467::AID-ART243>3.0.CO;2-6. View

del Rincon I, Williams K, Stern M, Freeman G, Escalante A . High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2002; 44(12):2737-45. DOI: 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-%23. View

Wallberg-Jonsson S, Ohman M, Dahlqvist S . Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol. 1997; 24(3):445-51. View

10.

Symmons D, Jones M, Scott D, Prior P . Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol. 1998; 25(6):1072-7. View

11.

Lindqvist E, Eberhardt K . Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Ann Rheum Dis. 1999; 58(1):11-4. PMC: 1752757. DOI: 10.1136/ard.58.1.11. View

12.

Maradit-Kremers H, Crowson C, Nicola P, Ballman K, Roger V, Jacobsen S . Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005; 52(2):402-11. DOI: 10.1002/art.20853. View

13.

G Williams J, Mann R . Hospital episode statistics: time for clinicians to get involved?. Clin Med (Lond). 2002; 2(1):34-7. PMC: 4953168. DOI: 10.7861/clinmedicine.2-1-34. View

14.

Bjornadal L, Baecklund E, Yin L, Granath F, Klareskog L, Ekbom A . Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95. J Rheumatol. 2002; 29(5):906-12. View

15.

Goodson N, Wiles N, Lunt M, Barrett E, Silman A, Symmons D . Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum. 2002; 46(8):2010-9. DOI: 10.1002/art.10419. View

16.

Peltomaa R, Paimela L, Kautiainen H, Leirisalo-Repo M . Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis. Ann Rheum Dis. 2002; 61(10):889-94. PMC: 1753911. DOI: 10.1136/ard.61.10.889. View

17.

Bottle A, Hansell A, Aylin P . Hospital episode statistics: time for clinicians to get involved?. Clin Med (Lond). 2002; 2(5):483-4; author reply 484. PMC: 4953098. DOI: 10.7861/clinmedicine.2-5-483a. View

18.

Wolfe F, Freundlich B, Straus W . Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol. 2003; 30(1):36-40. View

19.

Gabriel S, Crowson C, Kremers H, Doran M, Turesson C, OFallon W . Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum. 2003; 48(1):54-8. DOI: 10.1002/art.10705. View

20.

Solomon D, Karlson E, Rimm E, Cannuscio C, Mandl L, Manson J . Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003; 107(9):1303-7. DOI: 10.1161/01.cir.0000054612.26458.b2. View